**
Recent research from Mount Sinai has uncovered troubling evidence that fetuses are exposed to significantly greater levels of per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals,” than previously understood. This study highlights a critical gap in our understanding of environmental toxins during pregnancy, suggesting that the health risks to unborn children may be far more severe than earlier estimates indicated.
Unprecedented Levels of PFAS Detected
A comprehensive analysis of 120 umbilical cord blood samples has revealed the presence of 42 distinct PFAS compounds, vastly surpassing the limited number typically monitored, such as PFOA and PFOS. This expanded “non-targeted analysis” approach has brought to light the extent of fetal exposure to these harmful chemicals, which are notorious for their persistence in the environment and human body. Co-author of the study, Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai, remarked, “It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
PFAS are a vast class of over 15,000 synthetic chemicals, widely used for their ability to make products resistant to water, stains, and grease. Their link to serious health issues—including cancer, birth defects, immune system dysfunction, and more—has led to growing concerns about their impact on human health, particularly during critical developmental periods.
The Scope of PFAS Exposure
The implications of this research are stark. A review of existing studies has shown that PFAS have been detected in over 30,000 umbilical cord blood samples. Elevated levels in mothers are associated with increased infant mortality rates and adverse long-term effects on child health, including low birth weight and obesity. Moreover, fetal exposure has been linked to heightened risks of cancer, neurological disorders, and cardiovascular issues later in life.
Historically, legacy PFAS compounds like PFOA and PFOS dominated the market until recent regulatory shifts began phasing these out. However, chemical manufacturers have introduced newer PFAS generations that are often claimed to be less toxic—claims that frequently lack substantial evidence. The reality is that these newer compounds may also break down into more harmful substances once they interact with the environment or biological systems.
Inadequate Regulatory Oversight
The study underscores a critical issue: regulatory bodies have been slow to adapt their testing methodologies to account for the evolving landscape of PFAS chemicals. The U.S. Environmental Protection Agency (EPA), for instance, has typically only tested water samples for about 30-40 PFAS compounds, despite independent research identifying thousands in various environmental samples. This discrepancy leads to significant underreporting of PFAS levels, as highlighted by a 2022 analysis revealing that regulators frequently underestimated the concentrations found in water supplies.
Mount Sinai’s research effectively compared traditional testing methods with their more comprehensive analysis, confirming what many had suspected: the limited scope of existing tests has resulted in a gross underestimation of fetal PFAS exposure. While the EPA has recently begun to certify blood tests for 53 compounds, the Mount Sinai study identified 31 additional compounds not included in the EPA’s parameters, demonstrating the urgent need for enhanced regulatory measures.
The Path Forward
As the research community grapples with these findings, the health implications for infants remain a pressing concern. The study did not directly assess the health consequences of increased PFAS levels in fetal blood; however, Liu cautioned that higher concentrations are generally correlated with increased health risks. The blood samples analysed were part of the federal government’s Home study, which aims to track PFAS exposure and related health outcomes over time.
David Andrews, acting chief science officer at the Environmental Working Group (EWG), emphasized the importance of this research, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The implications of this study extend far beyond academic interest; they present a clarion call for immediate action to protect the health of vulnerable populations, particularly unborn children. With fetuses likely exposed to a cocktail of PFAS compounds, the need for stringent regulations and comprehensive testing protocols is urgent. As society grapples with the long-term effects of pollution on health, it becomes imperative to prioritise the development of effective measures to safeguard future generations from the dangers of these persistent environmental toxins.
